+1 862-686-2696

  • Buy 1 Get 1 FREE for immortalized cells| limited time until end of June

  • Boost Your Research with FREE Freezing Medium

Featured Products
Primary Cells
Immortalized Cell Lines
Stem Cells
Tumor Cell Lines
Transfected Stable Cell Lines
Exosomes
MicroRNA Agomir/Antagomir
Cell Culture Media, Kits & Reagents
Explore Products
Cell
Cell
MicroRNA
MicroRNA
Test and Analysis
Test and Analysis
Primary Cells

Human Multiple Myeloma PB Plasma (Newly Diagnosed/Untreated)

  • For research use only

Cat No.

ABC-TC3952
Product Type

Blood Products
Cell Type

Plasma
Species

Human
Growth Conditions

37 ℃, 5% CO2
Source Organ

Peripheral Blood
Disease

Multiple Myeloma
Storage

Liquid Nitrogen

Multiple Myeloma-PB-Plasma is obtained by centrifugation of Multiple Myeloma peripheral blood.

Product Image
  • Human Multiple Myeloma PB Plasma (Newly Diagnosed/Untreated)
Get a Quote
Home | Primary Cells | Human Primary Cells | Blood System Primary Cells | Human Multiple Myeloma PB Plasma (Newly Diagnosed/Untreated)

Description

Human Multiple Myeloma PB Plasma (Newly Diagnosed/Untreated) is derived from the peripheral blood (PB) of donors newly diagnosed with multiple myeloma and naive to systemic therapy. This plasma is immediately cryopreserved to preserve soluble components relevant to research use. Functionally, this plasma exhibits characteristic profiles associated with immune and metabolic alterations in myeloma, and contains detectable levels of pro-inflammatory cytokines and monoclonal proteins. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.

Product Code

Human Multiple Myeloma PB Plasma (Newly Diagnosed/Untreated), MM Peripheral Plasma, Untreated Myeloma PB Plasma, Newly Diagnosed MM Peripheral Plasma
Species

Human
Cat.No

ABC-TC3952
Product Category

Primary Cells
Size/Quantity

1 vial
Cell Type

Plasma
Shipping Info

Dry Ice
Growth Conditions

37 ℃, 5% CO2
Source Organ

Peripheral Blood
Disease

Multiple Myeloma
Biosafety Level

1
Storage

Liquid Nitrogen
Product Type

Blood Products
Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Application

  • Human Multiple Myeloma PB Plasma (Newly Diagnosed/Untreated) serves as an in vitro model to study early-stage myeloma pathogenesis. By analyzing its cytokine profiles, autoantibody content, and effects on immune cell function, researchers can explore molecular mechanisms driving disease initiation and immune evasion, supporting discovery research and target identification for myeloma-associated immune profiles.

Citation

When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

  • Online Inquiry
  • Product Reviews

Inquiring Human Multiple Myeloma PB Plasma (Newly Diagnosed/Untreated)

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

Let's Advance Life Science Research Together

Contact Us
AcceGen Scroll Top Button